1. Introduction: Bionauts™ are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely
2 Founders: Bionaut Labs is lead by 3 amazing leaders:
- Aviad Maizels, Executive Chairman and Founder
- Michael Shpigelmacher, CEO and Founder
- Alex Shpunt, Founder
3. Poblem & Solution:
Patients suffering from debilitating brain diseases have only a few treatment options and with limited impact or results. Conditions i.e. glioma and Parkinson's disease has large unmet medical need
Bionaut solution is a new direction in precision-targeted medicine Microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas to help patients suffering from severe brain disorders. So Bionaut is a fusion of a platform and a therapeutic into a new modality
4. Technology:
- Bionaut Sends Robots into the Human Body to Treat Disease
- Bionaut Labs targets disease with remote-controlled micro-robots
You have already seen the video.
5.Product
- Bionaut micro-robot
- Bionaut Platform:
The Bionaut™ platform, is a marketplace to develop and manage the pipeline of partnership opportunities across multiple high-value clinical indications and therapies to advance the technology to patients.
6. Market & Position
Its 500B market and CAGE 9.4% according to stats providers and potential to be 1T by 2030.
In the targeted market drug deliver, Bionaut is the leading the pack where other key players are Lineage, Sana, Priavoid, Caribou with significant investment and progress.
7. Business Model
- Custom-engineered therapeutic micro-robots is the primary product to use in target medicine delivery.
- Bionaut ™M platform, we have already talked about it.
- Growth from Partnership with clinical indications & therapies using the Bionaut platform
8. Competition
- Sana BioTech - Engineered Cells As Medicines
Repairing and controlling genes in cells or replacing missing or damaged cells can solve the underlying cause of many diseases. These emerging capabilities will create novel medicines that meaningfully improve patient outcomes, and Sana aims to lead the way.
9. Progress and Traction
In a very recent news, Bionaut Labs and Candel Therapeutics Announce Strategic Collaboration in Precision-Targeted Delivery of Oncolytic Viral Immunotherapies.
In another news, FDA Grants Humanitarian Use Device Designation to Bionaut Labs for Treatment of Dandy Walker Syndrome
In summary we can say that:
- Product ready, Animal testing done, FDA approvals
- Bionaut™M robots to treat pediatric neurological disorder
- FDA approves local treatment of all malignant gliomas
10. Outlook
- Significant traction is there through partnership.
- Bionaut is backed by great VC team so money will not be problem if product is working as expected and FDA approvals are keep coming.
- Based on Market, It's 500B market now and in 10 years could be doubled so growth is significant and Bionaut is in a great place.
Bionaut Review Content:
----------------------------------------------
- (00:00) Video Starts
- (0:07) Bionaut actual product video
- (1:10) Startup Review 10 Points Strategy
- (2:01) Bionaut Promo Video
- (2:48) Bionaut Introduction
- (5:00) Founders
- (6:30) Problem and Solution
- (7:54) Technology
- (9:52) Product Details
- (11:41) Market & Positioning
- (12:47) Business Model
- (13:32) Competition
- (15:06) Current Progress/Traction
- (17:02) Outlook
- (18:20) Credits
Please visit:
Prodramp LLC
https://prodramp.com@prodramp
https://www.linkedin.com/company/prodrampWe Together Ventures
https://wetogether.vc@wetogethervc
Content Creator:
Avkash Chauhan (@avkashchauhan)
https://www.linkedin.com/in/avkashchauhanTags:
#angelinvestment #angelinvestor #prodramp #wetogethervc
#nervoussystemdisorders @bionaut @bainaut #Biopharma
#Biotechnology #HealthCare #Therapeutics #Robots #microrobots
...
https://www.youtube.com/watch?v=mlL_p7QgUZI